• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution.诺如病毒 GII.4 流行变异株中血凝素-血红细胞抗原结合特异性的结构分析:对新纪元进化的启示。
J Virol. 2011 Sep;85(17):8635-45. doi: 10.1128/JVI.00848-11. Epub 2011 Jun 29.
2
Human noroviruses' fondness for histo-blood group antigens.人类诺如病毒对组织血型抗原的偏好。
J Virol. 2015 Feb;89(4):2024-40. doi: 10.1128/JVI.02968-14. Epub 2014 Nov 26.
3
Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses.结构分析决定因子在 I 组诺如病毒的组织血型抗原结合特异性。
J Virol. 2014 Jun;88(11):6168-80. doi: 10.1128/JVI.00201-14. Epub 2014 Mar 19.
4
Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability.GII.10 和 GII.12 诺如病毒突起结构域与血型抗原复合物的晶体结构揭示了潜在弱点的详细信息。
J Virol. 2011 Jul;85(13):6687-701. doi: 10.1128/JVI.00246-11. Epub 2011 Apr 27.
5
Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket.一种针对组织血型抗原口袋的单克隆抗体中和人类诺如病毒。
J Virol. 2019 Feb 19;93(5). doi: 10.1128/JVI.02174-18. Print 2019 Mar 1.
6
Mechanisms of GII.4 norovirus persistence in human populations.GII.4型诺如病毒在人群中持续存在的机制。
PLoS Med. 2008 Feb;5(2):e31. doi: 10.1371/journal.pmed.0050031.
7
Structural analysis of a rabbit hemorrhagic disease virus binding to histo-blood group antigens.兔出血症病毒与组织血型抗原结合的结构分析
J Virol. 2015 Feb;89(4):2378-87. doi: 10.1128/JVI.02832-14. Epub 2014 Dec 10.
8
Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.嵌合 VLPs 具有 GII.4 VP1 骨架中的 GII.3 P2 结构域,赋予其新型 HBGA 结合能力。
Virus Res. 2016 Sep 15;224:1-5. doi: 10.1016/j.virusres.2016.08.006. Epub 2016 Aug 10.
9
Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens.GI.4 诺如病毒变异体与人血型抗原结合的定性和定量分析。
J Virol. 2011 May;85(9):4057-70. doi: 10.1128/JVI.02077-10. Epub 2011 Feb 23.
10
Structural Basis for Human Norovirus Capsid Binding to Bile Acids.人诺如病毒衣壳与胆汁酸结合的结构基础。
J Virol. 2019 Jan 4;93(2). doi: 10.1128/JVI.01581-18. Print 2019 Jan 15.

引用本文的文献

1
Determining the Importance of Carbohydrate-Based Structures in Murine Norovirus Binding to Commensal Bacteria.确定基于碳水化合物的结构在小鼠诺如病毒与共生细菌结合中的重要性。
Viruses. 2025 Aug 20;17(8):1142. doi: 10.3390/v17081142.
2
Genetic diversity of norovirus in Shenzhen Based on continuous surveillance from 2016 to 2022.基于2016年至2022年持续监测的深圳诺如病毒基因多样性
Front Cell Infect Microbiol. 2025 Jun 18;15:1593610. doi: 10.3389/fcimb.2025.1593610. eCollection 2025.
3
spp. interacts with human norovirus in clinical samples and impairs its replication on human intestinal enteroids.某物种在临床样本中与人类诺如病毒相互作用,并损害其在人肠道类器官上的复制。
Gut Microbes. 2025 Dec;17(1):2469716. doi: 10.1080/19490976.2025.2469716. Epub 2025 Mar 3.
4
A Nanoparticle Comprising the Receptor-Binding Domains of Norovirus and as a Combination Vaccine Candidate.一种包含诺如病毒受体结合结构域的纳米颗粒作为联合疫苗候选物。
Vaccines (Basel). 2025 Jan 1;13(1):34. doi: 10.3390/vaccines13010034.
5
Norovirus replication, host interactions and vaccine advances.诺如病毒的复制、宿主相互作用及疫苗进展。
Nat Rev Microbiol. 2025 Jun;23(6):385-401. doi: 10.1038/s41579-024-01144-9. Epub 2025 Jan 17.
6
Conformational Flexibility in Capsids Encoded by the .由……编码的衣壳中的构象灵活性 。 你提供的原文似乎不完整,“the.”后面应该还有具体内容。
Viruses. 2024 Nov 26;16(12):1835. doi: 10.3390/v16121835.
7
Development of a broad-spectrum therapeutic Fc-nanobody for human noroviruses.广谱人诺如病毒治疗性 Fc-纳米抗体的研制。
J Virol. 2024 Jul 23;98(7):e0070724. doi: 10.1128/jvi.00707-24. Epub 2024 Jul 2.
8
Antigenic Characterization of Novel Human Norovirus GII.4 Variants San Francisco 2017 and Hong Kong 2019.新型人诺如病毒 GII.4 变异株旧金山 2017 年和香港 2019 年的抗原特征。
Emerg Infect Dis. 2024 May;30(5):1026-1029. doi: 10.3201/eid3005.231694.
9
A single nanobody neutralizes multiple epochally evolving human noroviruses by modulating capsid plasticity.单纳米抗体通过调节衣壳可塑性来中和多种不断进化的人类诺如病毒。
Nat Commun. 2023 Oct 16;14(1):6516. doi: 10.1038/s41467-023-42146-0.
10
Immunogenicity and Blocking Efficacy of Norovirus GII.4 Recombinant P Protein Vaccine.诺如病毒GII.4重组P蛋白疫苗的免疫原性及阻断效果
Vaccines (Basel). 2023 Jun 1;11(6):1053. doi: 10.3390/vaccines11061053.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens.GI.4 诺如病毒变异体与人血型抗原结合的定性和定量分析。
J Virol. 2011 May;85(9):4057-70. doi: 10.1128/JVI.02077-10. Epub 2011 Feb 23.
3
Insight into the mechanism of the influenza A proton channel from a structure in a lipid bilayer.从脂质双层中的结构深入了解甲型流感质子通道的机制。
Science. 2010 Oct 22;330(6003):509-12. doi: 10.1126/science.1191750.
4
Norovirus gastroenteritis, carbohydrate receptors, and animal models.诺如病毒肠胃炎、碳水化合物受体与动物模型。
PLoS Pathog. 2010 Aug 26;6(8):e1000983. doi: 10.1371/journal.ppat.1000983.
5
Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008.1987 年至 2008 年期间流行的 GII-4 诺如病毒的遗传和表型特征。
J Virol. 2010 Sep;84(18):9595-607. doi: 10.1128/JVI.02614-09. Epub 2010 Jun 30.
6
Viral shape-shifting: norovirus evasion of the human immune system.病毒变形:诺如病毒逃避人体免疫系统。
Nat Rev Microbiol. 2010 Mar;8(3):231-41. doi: 10.1038/nrmicro2296. Epub 2010 Feb 2.
7
PHENIX: a comprehensive Python-based system for macromolecular structure solution.PHENIX:一个基于Python的用于大分子结构解析的综合系统。
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21. doi: 10.1107/S0907444909052925. Epub 2010 Jan 22.
8
Evolutionary dynamics of GII.4 noroviruses over a 34-year period.34年间GII.4型诺如病毒的进化动态
J Virol. 2009 Nov;83(22):11890-901. doi: 10.1128/JVI.00864-09. Epub 2009 Sep 16.
9
Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007.诺如病毒疾病是一个全球性问题:2001年至2007年诺如病毒GII.4变体的出现和传播。
J Infect Dis. 2009 Sep 1;200(5):802-12. doi: 10.1086/605127.
10
Phaser crystallographic software.相位结晶学软件。
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674. doi: 10.1107/S0021889807021206. Epub 2007 Jul 13.

诺如病毒 GII.4 流行变异株中血凝素-血红细胞抗原结合特异性的结构分析:对新纪元进化的启示。

Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution.

机构信息

Verna Marrs Mclean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.

出版信息

J Virol. 2011 Sep;85(17):8635-45. doi: 10.1128/JVI.00848-11. Epub 2011 Jun 29.

DOI:10.1128/JVI.00848-11
PMID:21715503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3165782/
Abstract

Susceptibility to norovirus (NoV), a major pathogen of epidemic gastroenteritis, is associated with histo-blood group antigens (HBGAs), which are also cell attachment factors for this virus. GII.4 NoV strains are predominantly associated with worldwide NoV epidemics with a periodic emergence of new variants. The sequence variations in the surface-exposed P domain of the capsid protein resulting in differential HBGA binding patterns and antigenicity are suggested to drive GII.4 epochal evolution. To understand how temporal sequence variations affect the P domain structure and contribute to epochal evolution, we determined the P domain structure of a 2004 variant with ABH and secretor Lewis HBGAs and compared it with the previously determined structure of a 1996 variant. We show that temporal sequence variations do not affect the binding of monofucosyl ABH HBGAs but that they can modulate the binding strength of difucosyl Lewis HBGAs and thus could contribute to epochal evolution by the potentiated targeting of new variants to Lewis-positive, secretor-positive individuals. The temporal variations also result in significant differences in the electrostatic landscapes, likely reflecting antigenic variations. The proximity of some of these changes to the HBGA binding sites suggests the possibility of a coordinated interplay between antigenicity and HBGA binding in epochal evolution. From the observation that the regions involved in the formation of the HBGA binding sites can be conformationally flexible, we suggest a plausible mechanism for how norovirus disassociates from salivary mucin-linked HBGA before reassociating with HBGAs linked to intestinal epithelial cells during its passage through the gastrointestinal tract.

摘要

诺如病毒(NoV)是引起流行性肠胃炎的主要病原体之一,其易感性与组织血型抗原(HBGAs)有关,HBGAs 也是该病毒的细胞附着因子。GII.4 诺如病毒株与全球范围内的 NoV 流行密切相关,并定期出现新的变异株。衣壳蛋白表面暴露的 P 结构域的序列变异导致不同的 HBGA 结合模式和抗原性,被认为是推动 GII.4 时期进化的原因。为了了解时间序列变异如何影响 P 结构域的结构并促进时期进化,我们测定了具有 ABH 和分泌型 Lewis HBGAs 的 2004 年变异株的 P 结构域结构,并将其与之前确定的 1996 年变异株的结构进行了比较。我们表明,时间序列变异不会影响单岩藻糖基 ABH HBGAs 的结合,但可以调节双岩藻糖基 Lewis HBGAs 的结合强度,从而通过新变异株对 Lewis 阳性、分泌型阳性个体的靶向增强来促进时期进化。时间变化还导致静电景观的显著差异,可能反映了抗原变化。这些变化中的一些与 HBGA 结合位点接近,表明在时期进化中抗原性和 HBGA 结合之间可能存在协调作用。从参与形成 HBGA 结合位点的区域的可变性观察,我们提出了一种合理的机制,解释了诺如病毒如何在通过胃肠道的过程中与肠道上皮细胞连接的 HBGAs 重新结合之前,从唾液黏蛋白连接的 HBGA 上解离。